Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M408473200 on September 22, 2004

J. Biol. Chem., Vol. 279, Issue 51, 53524-53532, December 17, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/51/53524    most recent
M408473200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christensen, R. A.
Right arrow Articles by Querfurth, H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christensen, R. A.
Right arrow Articles by Querfurth, H. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Calcium Dyshomeostasis in {beta}-Amyloid and Tau-bearing Skeletal Myotubes*

Rial A. Christensen{ddagger}§, Alexander Shtifman¶§, Paul D. Allen¶, Jose R. Lopez¶, and Henry W. Querfurth{ddagger}||

From the {ddagger}Department of Neurology, Caritas St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02135 and the Department of Anesthesia, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115

The relative scarcity of inclusion-affected muscle cells or markers of cell death in inclusion body myositis (IBM) is in distinction to the specific and early intracellular deposition of several Alzheimer's Disease (AD)-related proteins. The current study examined the possible correlation between myotube {beta}-amyloid and/or Tau accumulations and a widespread mishandling of intracellular muscle calcium concentration that could potentially account for the unrelenting weakness in affected patients. Cultured myogenic cells (C2C12) expressed {beta}-amyloid-42 (A{beta}42) and fetal Tau peptides, as human transgenes encoded by herpes simplex virus, either individually or concurrently. Co-expression of A{beta}42 in C2C12 myotubes resulted in hyperphosphorylation of Tau protein that was not observed when Tau was expressed alone. Resting calcium concentration and agonist-induced RyR-mediated Ca2+ release were examined using calcium-specific microelectrodes and Fluo-4 epifluorescence, respectively. Co-expression of A{beta}42 and Tau cooperatively elevated basal levels of myoplasmic-free calcium, an effect that was accompanied by depolarization of the plasma membrane. Sarcoplasmic reticulum (SR) calcium release, induced by KCl depolarization, was not affected by A{beta}42 or Tau. In contrast, expression of A{beta}42, Tau, or A{beta}42 together with Tau resulted in enhanced sensitivity of ryanodine receptors to activation by caffeine. Notably, expression of {beta}-amyloid, alone, was sufficient to result in an increased sensitivity to direct activation by caffeine. Current results indicate that amyloid proteins cooperate to raise resting calcium levels and that these effects are associated with a passive SR Ca2+ leak and Tau hyperphosphorylation in skeletal muscle.


Received for publication, July 27, 2004 , and in revised form, September 21, 2004.

* This work was supported by National Institutes of Health Grant 1F32AR049160-1 (to A. S.), a grant from The Myositis Association, and NINDS National Institutes of Health Grants R01 NSO41373(to H. W. Q.) and 5R01ARO46513 (to P. D. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Both authors contributed equally to this work.

|| To whom correspondence should be addressed: Caritas St. Elizabeth's Medical Center, Tufts University, 736 Cambridge St. Boston, MA 02135. Tel.: 617-789-2375; Fax: 617-789-5177; E-mail: henry.querfurth{at}tufts.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. Bravo, M. Arimon, J. J. Valle-Delgado, R. Garcia, N. Durany, S. Castel, M. Cruz, S. Ventura, and X. Fernandez-Busquets
Sulfated Polysaccharides Promote the Assembly of Amyloid {beta}1-42 Peptide into Stable Fibrils of Reduced Cytotoxicity
J. Biol. Chem., November 21, 2008; 283(47): 32471 - 32483.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. Schmidt, K. Barthel, A. Wrede, M. Salajegheh, M. Bahr, and M. C. Dalakas
Interrelation of inflammation and APP in sIBM: IL-1{beta} induces accumulation of {beta}-amyloid in skeletal muscle
Brain, May 1, 2008; 131(5): 1228 - 1240.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Kitazawa, K. N. Green, A. Caccamo, and F. M. LaFerla
Genetically Augmenting A{beta}42 Levels in Skeletal Muscle Exacerbates Inclusion Body Myositis-Like Pathology and Motor Deficits in Transgenic Mice
Am. J. Pathol., June 1, 2006; 168(6): 1986 - 1997.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement